Choritz Lars

Telemetric Measurement of Intraocular Pressure via an Implantable Pressure Sensor-12-Month Results from the ARGOS-02 Trial.

The EYEMATE-IO sensor was safely implanted in 22 patients and performed reliably until the end of follow-up. This device allows for continual and long-term measurements of IOP.

Intraocular Pressure Telemetry for Managing Glaucoma during the COVID-19 Pandemic.

These results show the feasibility of patient-acquired measurement of IOP in conjunction with remote IOP monitoring by physicians with an implantable sensor.

Implanted Microsensor Continuous IOP Telemetry Suggests Gaze and Eyelid Closure Effects on IOP-A Preliminary Study.

Our data suggest that IOP varies reproducibly with gaze direction, albeit with patient variability.

The Value of Intraocular Pressure Telemetry in Monitoring the Therapeutic Effect of Glaucoma Medications.

Assessment of the effect of physical activity on intraocular pressure using a novel implanted telemetric pressure sensor.

In our study, IOP, heart rate and blood pressure increased and decreased with physical intensity, suggesting these parameters are closely linked and potentially driven by a common mechanism during aerobic exercise.

Reproducibility of consecutive automated telemetric noctodiurnal IOP profiles as determined by an intraocular implant.

Twenty-four hour automatic measurements of IOP are correlated on consecutive days and, though to a lesser degree, with self-measurements.